Drug-Device Combination Product Patents: The Strategic Playbook for Turning Regulatory Complexity into Market Lock-In
The pharmaceutical industry loves a good narrative about convergence. Drugs are meeting devices. Biologics are meeting sensors. Software is meeting […]
